SANDRA OKERE: Open Payments
NPI 1104323344 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,092 in 58 payments from 13 companies in 2025. Trend: 2023 $885 · 2024 $1,042 · 2025 $2,092
Food & beverage: $2,092
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $731 |
| GENZYME CORPORATION | 12 | $620 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $242 |
| Optinose US, Inc. | 7 | $147 |
| Organon LLC | 6 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Incyte Corporation | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $23 |
Products named: DUPIXENT, AIRSUPRA, BREZTRI, NEFFY, Xhance, TAKHZYRO, VTAMA, Xolair.
Industry payments across TX — which companies pay providers there.
